Better Money Decisions, LLC Eli Lilly & CO Transaction History

Better Money Decisions, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	BUY	$278.73 - $327.27 $31,496 - $36,981	113 New	113 $37,000
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $62,733 - $77,852	-279 Closed	0 $0
Q2 2021 Jul 22, 2021	BUY	$180.55 - $233.54 $5,597 - $7,239	31 Added 12.5%	279 $64,000
Q1 2021 May 04, 2021	BUY	$164.32 - $212.72 $40,751 - $52,754	248 New	248 $46,000

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Better Money Decisions, LLC, based on Form 13F filings with the SEC.

Stay updated on Better Money Decisions, LLC with notifications on news.